mRNA（メッセンジャーリボ核酸）ワクチン・治療薬の世界市場は、予測期間の2022年から2028年には16.8％以上の健全な成長率で成長すると予測されています。メッセンジャーリボ核酸（mRNA）は、ゲノムに見られる単一のタンパク質コード遺伝子であり、細胞内でのタンパク質合成の基盤として機能します。mRNAワクチンと治療法は、哺乳類細胞を利用した実験室で行われ、良好な免疫学的特性を持ちます。非複製、in vivo自己複製、自己増幅、およびin vitro樹状細胞非複製mRNAは、ワクチンおよび治療の最も頻繁な形態の一部です。それらは体内に注入されてウイルス検出免疫センサーを活性化し、細胞にウイルス抗原タンパク質を生成させます。B細胞およびT細胞の反応を増加させることにより、体の免疫力の向上に貢献します。市場の成長は、癌の有病率の上昇や予防接種についての意識の高まりなどの重要な要因によって推進されています。Statistaによると、2020年に最も多かった癌の形態は乳癌で、10万人あたりおよそ48人の女性が診断されました。前立腺癌は、当時の12カ月有病率が10万人あたり30.4人でした。しかし、治療薬に対する需要の高まりが、2022年から2028年の予測期間における市場の成長を阻害しています。
mRNA（メッセンジャーリボ核酸）ワクチン・治療薬の世界市場調査において考慮した主要地域には、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域が含まれます。北アメリカは市場シェアをリードしており、予測期間中に最も急速に成長する地域となることが予想されます。市場の成長を支える要因は、有力企業の豊富な存在と、アメリカにおけるCOVID-19患者の急激な急増です。
この調査の目的は、近年のさまざまなセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品内容の詳細な分析とともに、利害関係者が投資できるミクロ市場での機会についても報告します。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. mRNA Vaccines and Therapeutics Market, by Region, 2020-2028 (USD Billion)
1.2.2. mRNA Vaccines and Therapeutics Market, by MRNA Type, 2020-2028 (USD Billion)
1.2.3. mRNA Vaccines and Therapeutics Market, by Application, 2020-2028 (USD Billion)
1.2.4. mRNA Vaccines and Therapeutics Market, by End-User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global mRNA Vaccines and Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global mRNA Vaccines and Therapeutics Market Dynamics
3.1. mRNA Vaccines and Therapeutics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rise in prevalence of cancer
3.1.1.2. Increase in awareness about vaccination
3.1.2. Market Challenges
3.1.2.1. Growing demand for therapeutic medicines
3.1.3. Market Opportunities
3.1.3.1. Developments in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA
Chapter 4. Global mRNA Vaccines and Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global mRNA Vaccines and Therapeutics Market, by MRNA Type
6.1. Market Snapshot
6.2. Global mRNA Vaccines and Therapeutics Market by mRNA Type, Performance - Potential Analysis
6.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by mRNA Type, 2018-2028 (USD Billion)
6.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
6.4.1. Nucleoside-Modified mRNA (modRNA)
6.4.2. Unmodified mRNA
6.4.3. Self-Amplifying mRNA
Chapter 7. Global mRNA Vaccines and Therapeutics Market, by Application
7.1. Market Snapshot
7.2. Global mRNA Vaccines and Therapeutics Market by Application, Performance - Potential Analysis
7.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
7.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
7.4.1. COVID mRNA Application
7.4.2. Non-COVID mRNA Application
Chapter 8. Global mRNA Vaccines and Therapeutics Market, by End-User
8.1. Market Snapshot
8.2. Global mRNA Vaccines and Therapeutics Market by End-User, Performance - Potential Analysis
8.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by End-User, 2018-2028 (USD Billion)
8.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
8.4.1. Hospitals & healthcare Clinics
8.4.2. Research Organisation & Institutions
8.4.3. Others
Chapter 9. Global mRNA Vaccines and Therapeutics Market, Regional Analysis
9.1. mRNA Vaccines and Therapeutics Market, Regional Market Snapshot
9.2. North America mRNA Vaccines and Therapeutics Market
9.2.1. U.S. mRNA Vaccines and Therapeutics Market
9.2.1.1. mRNA Type breakdown estimates & forecasts, 2018-2028
9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
9.2.1.3. End-User breakdown estimates & forecasts, 2018-2028
9.2.2. Canada mRNA Vaccines and Therapeutics Market
9.3. Europe mRNA Vaccines and Therapeutics Market Snapshot
9.3.1. U.K. mRNA Vaccines and Therapeutics Market
9.3.2. Germany mRNA Vaccines and Therapeutics Market
9.3.3. France mRNA Vaccines and Therapeutics Market
9.3.4. Spain mRNA Vaccines and Therapeutics Market
9.3.5. Italy mRNA Vaccines and Therapeutics Market
9.3.6. Rest of Europe mRNA Vaccines and Therapeutics Market
9.4. Asia-Pacific mRNA Vaccines and Therapeutics Market Snapshot
9.4.1. China mRNA Vaccines and Therapeutics Market
9.4.2. India mRNA Vaccines and Therapeutics Market
9.4.3. Japan mRNA Vaccines and Therapeutics Market
9.4.4. Australia mRNA Vaccines and Therapeutics Market
9.4.5. South Korea mRNA Vaccines and Therapeutics Market
9.4.6. Rest of Asia Pacific mRNA Vaccines and Therapeutics Market
9.5. Latin America mRNA Vaccines and Therapeutics Market Snapshot
9.5.1. Brazil mRNA Vaccines and Therapeutics Market
9.5.2. Mexico mRNA Vaccines and Therapeutics Market
9.6. Rest of The World mRNA Vaccines and Therapeutics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Gennova Biopharmaceuticals Ltd
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. ProductSummary
10.2.1.5. Recent Developments
10.2.2. Arcturus Therapeutics Holdings Inc.
10.2.3. Providence Therapeutics
10.2.4. CureVac N.V.
10.2.5. GlaxoSmithKline plc
10.2.6. Pantherna Therapeutics GmbH
10.2.7. Silence Therapeutics
10.2.8. Ethris GmbH
10.2.9. BioNTech
10.2.10. Versameb AG
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
List of Tables
TABLE 1. Global mRNA Vaccines and Therapeutics market, report scope
TABLE 2. Global mRNA Vaccines and Therapeutics market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global mRNA Vaccines and Therapeutics market estimates & forecasts by mRNA Type 2018-2028 (USD Billion)
TABLE 4. Global mRNA Vaccines and Therapeutics market estimates & forecasts by Application 2018-2028 (USD Billion)
TABLE 5. Global mRNA Vaccines and Therapeutics market estimates & forecasts by End User 2018-2028 (USD Billion)
TABLE 6. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. U.S. mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 18. U.S. mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. Canada mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 20. Canada mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. Canada mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. UK mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 23. UK mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. UK mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. Germany mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 26. Germany mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. Germany mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. RoE mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 29. RoE mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. RoE mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. China mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 32. China mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. China mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. India mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 35. India mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. India mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. Japan mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 38. Japan mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. Japan mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. RoAPAC mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 41. RoAPAC mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. RoAPAC mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. Brazil mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 44. Brazil mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Brazil mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Mexico mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 47. Mexico mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. Mexico mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. RoLA mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 50. RoLA mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. RoLA mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. Row mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 53. Row mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. Row mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global mRNA Vaccines and Therapeutics market
TABLE 56. List of primary sources, used in the study of global mRNA Vaccines and Therapeutics market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
List of figures
FIG 1. Global RNA Vaccines and Therapeutics market, research methodology
FIG 2. Global mRNA Vaccines and Therapeutics market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global mRNA Vaccines and Therapeutics market, key trends 2021
FIG 5. Global mRNA Vaccines and Therapeutics market, growth prospects 2022-2028
FIG 6. Global mRNA Vaccines and Therapeutics market, porters 5 force model
FIG 7. Global mRNA Vaccines and Therapeutics market, pest analysis
FIG 8. Global mRNA Vaccines and Therapeutics market, value chain analysis
FIG 9. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global mRNA Vaccines and Therapeutics market, regional snapshot 2018 & 2028
FIG 15. North America mRNA Vaccines and Therapeutics market 2018 & 2028 (USD Billion)
FIG 16. Europe mRNA Vaccines and Therapeutics market 2018 & 2028 (USD Billion)
FIG 17. Asia Pacific mRNA Vaccines and Therapeutics market 2018 & 2028 (USD Billion)
FIG 18. Latin America mRNA Vaccines and Therapeutics market 2018 & 2028 (USD Billion)
FIG 19. Global mRNA Vaccines and Therapeutics market, company market share analysis (2021)
